Julie A. Urban, Ph.D.
Affiliations: | 2006 | Northwestern University, Evanston, IL |
Area:
ImmunologyGoogle:
"Julie Urban"Parents
Sign in to add mentorSusan Winandy | grad student | 2006 | Northwestern | |
(The dichotomous role of Ikaros in T cell development.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Obermajer N, Urban J, Wieckowski E, et al. (2018) Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. Nature Protocols. 13: 335-357 |
Budiu RA, Vlad AM, Nazario L, et al. (2017) Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model. Cancer and Clinical Oncology. 6: 12-24 |
Francis L, Guo ZS, Liu Z, et al. (2016) Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer. Oncotarget |
Kalinski P, Muthuswamy R, Urban J. (2013) Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies. Expert Review of Vaccines. 12: 285-95 |
Helfer BM, Balducci A, Urban J, et al. (2013) Abstract B44: Enabling in vivo visualization of cellular therapies in the clinic: Maturation of αDC1 data sets. Cancer Research. 73 |
Li J, O'Malley M, Urban J, et al. (2011) Chemokine expression from oncolytic vaccinia virus enhances vaccine therapies of cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 650-7 |
Watchmaker PB, Berk E, Muthuswamy R, et al. (2010) Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 591-7 |
Kalinski P, Urban J, Narang R, et al. (2009) Dendritic cell-based therapeutic cancer vaccines: What we have and what we need Future Oncology. 5: 379-390 |
Urban JA, Brugmann W, Winandy S. (2009) Cutting Edge: Ikaros null thymocytes mature into the CD4 lineage with reduced TCR signal: A study using CD3{zeta} immunoreceptor tyrosine-based activation motif transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 182: 3955-9 |
Giermasz AS, Urban JA, Nakamura Y, et al. (2009) Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. Cancer Immunology, Immunotherapy : Cii. 58: 1329-36 |